Evidence map›Paper›PMID 33324648›Full record

ArticleFrontiers in cell and developmental biology2020

TMEM132A, a Novel Wnt Signaling Pathway Regulator Through Wntless (WLS) Interaction.

Binbin Li, Lee A Niswander

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The role of Evi/Wntless in exporting Wnt proteins.Development (Cambridge, England) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Binbin LiDepartment of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, CO, United States.
Lee A NiswanderDepartment of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, CO, United States.
University of Colorado Boulder · US

Funding

Project II - Modeling meningomyelocele in frog using human alleles and folic acid exposureP01HD104436 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NISWANDER, LEE A. · 2021 to 2025
$7.0M
Phenotyping Embryonic Lethal Knockout mice with neural crest and neural defectsR01HD081562 · NICHD · UNIVERSITY OF COLORADO DENVER · PI CLOUTHIER, DAVID E., NISWANDER, LEE A. · 2014 to 2018
$3.3M
NICHD NIH HHS P01 HD104436NICHD NIH HHS R01 HD081562
6 · The paper itself

Abstract

Wnt signaling pathway plays indispensable roles in embryonic development and adult tissue homeostasis. However, the regulatory mechanisms involved in Wnt ligand trafficking within and secretion from the signal sending cells is still relatively uncharacterized. Here, we discover a novel regulator of Wnt signaling pathway called transmembrane protein 132A (TMEM132A). Our evidence shows a physical and functional interaction of TMEM132A with the Wnt ligand transporting protein Wntless (WLS). We show that TMEM132A stabilizes Wnt ligand, enhances WLS-Wnt ligand interaction, and activates the Wnt signaling pathway. Our results shed new light on the cellular mechanism underlying the fundamental aspect of WNT secretion from Wnt signal sending cells.

Indexed as

intracellular traffickingtransmembrane protein 132A (TMEM132A)Wntless (WLS)Wnt ligandWnt signaling pathway

Identifiers

PMID33324648
PMCPMC7726220
OpenAlexW3107214163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.